Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | TNDM | Common Stock | 8.41K | May 23, 2024 | Direct | ||||||
holding | TNDM | Common Stock | 1.94K | May 23, 2024 | Shannon M. Hansen Trust | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Restricted Stock Unit | Award | $0 | +13.2K | $0.00 | 13.2K | May 23, 2024 | Common Stock | 13.2K | Direct | F2, F3 | ||
transaction | TNDM | Performance Stock Unit | Award | $0 | +13.2K | $0.00 | 13.2K | May 23, 2024 | Common Stock | 13.2K | Direct | F4 |
Id | Content |
---|---|
F1 | The securities are held by the Shannon M. Hansen Trust dated July 8, 2003, of which Shannon M. Hansen is the Trustee. |
F2 | Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. |
F3 | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. |
F4 | Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2026 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest. |